Key actions identified to improve post-acute care for TBI patients

A new systematic literature search identified the highest priority clinical actions aimed at improving post-acute care for non-hospitalized traumatic brain injury (TBI). The study is published in the peer-reviewed Journal of Neurotrauma.

PhRMA urges court to stop government drug price negotiations before they start

Industry group PhRMA yesterday asked a Texas district court to halt CMS’ incoming drug price negotiations before they kick off in earnest next month. The

August 12, 2023

MaxCyte celebrates 25 years of innovation driving cell engineering-based therapeutics

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, marks the 25th anniversary

November 14, 2024

STAT’s most memorable photos of 2023

The past year has brought huge changes in medicine and science — from innovations like the first curative treatment for sickle cell to legislative restrictions

December 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.